New Resource from NYC Medical Malpractice Attorney Jonathan C. Reiter Now Available
NYC Medical Malpractice Attorney Jonathan C. Reiter Highlights the Impact of Medical Negligence on Patients
New York City, NY, June 01, 2025 (GLOBE NEWSWIRE) -- In a healthcare system where medical errors rank as the third leading cause of death in America, acclaimed NYC trial attorney Jonathan C. Reiter is jolting listeners from passive acceptance to active vigilance with his groundbreaking new podcast series, "Understanding Medical Malpractice and Its Impact."
The podcast transforms listeners' mental state from relaxed inattention to focused engagement, delivering critical insights for patients navigating the aftermath of medical negligence – from recognizing when standards of care have been breached to understanding the complex legal landscape of pursuing justice.
"Most patients don't realize they're victims of malpractice until it's almost too late to take action," says Reiter, whose decades of experience have secured millions in compensation for victims of medical negligence. "This podcast bridges the knowledge gap that exists between medical professionals and the patients they serve."
The debut episode explores the shocking prevalence of preventable medical errors, including surgical mistakes, misdiagnosis, birth injuries, and medication errors. Reiter provides listeners with a comprehensive framework for identifying potential malpractice and outlines the critical steps patients should take immediately following suspected negligence.
"Understanding the statute of limitations is crucial," Reiter emphasizes. "In New York, patients typically have just 2.5 years from the date of malpractice to file a lawsuit, but many victims spend much of that time simply trying to understand what happened to them."
Future episodes will feature interviews with medical experts, patient advocates, and survivors of medical negligence, creating a multifaceted resource for patients and their families. The podcast also examines the broader impact of medical malpractice on the healthcare system and explores potential reforms.
With his characteristic clarity and compassion, Reiter transforms complex legal concepts into accessible guidance for listeners. The podcast serves as a natural extension of his commitment to patient advocacy and healthcare accountability.
"Understanding Medical Malpractice and Its Impact" is available now on the website here.
About Jonathan C. Reiter
Jonathan C. Reiter Law Firm - Top NYC Medical Malpractice Lawyer, Releases New Legal Resource
Jonathan C. Reiter is a prominent New York City medical malpractice and personal injury attorney. With over 30 years of experience, he has established himself as one of NYC's premier legal advocates for victims of medical negligence. His firm, the Jonathan C. Reiter Law Firm, PLLC, has secured substantial verdicts and settlements for clients affected by medical errors, helping them rebuild their lives after devastating injuries.
Media Contact:
Jonathan C. Reiter Law Firm, PLLC www.jcreiterlaw.com
T: 212-736-0979
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hamilton Spectator
an hour ago
- Hamilton Spectator
Bill 33 attacks local democracy, public education and Ontario's most vulnerable kids
Toronto, ON, June 03, 2025 (GLOBE NEWSWIRE) — Last week, the Ontario government introduced Bill 33, a sweeping piece of legislation that hands more control over education to the premier's office at the direct expense of school boards, post-secondary institutions, and the communities that depend on them. 'Bill 33 is a power grab, and a dangerous one,' said OPSEU/SEFPO President JP Hornick. 'This government is using isolated examples of financial mismanagement to justify sweeping changes to multiple levels of our public education system, instead of addressing the real issue—underfunding.' If passed, Bill 33 would: make it easier for the province to take control of democratically elected local school boards; mandate School Resource Officers (i.e., police) in schools (even though such programs have previously been ended for their discriminatory and harmful impacts and do not offer the solutions needed to address increasing violence in schools); regulate which fees post-secondary students can pay (opening the door to defunding crucial student supports); and threaten access to education with new admissions policies at the province's colleges and universities, among other measures. 'These moves represent an unwarranted expansion of provincial authority. Instead of fixing the funding crisis it created, the Ford government is seizing control and calling it reform,' said Hornick. 'Our colleges, our schools, and our students deserve better.' Public educational institutions are meant to be built on equitable access and student success, but Bill 33 will undercut these principles while failing to address the systemic issues that face Ontario's education system. 'The mandated placement of SROs outlined in this bill does nothing to support the students and staff that are dealing with unprecedented levels of violence in Ontario schools,' said Kelly Martin, President of OPSEU/SEFPO Local 330, representing workers at Simcoe County District School Board. 'We need solutions that give children access to the wrap around supports that they need to thrive – like more education workers, smaller class sizes, increased mental health supports and special education supports that meet the needs of students.' 'It is unconscionable that this government is considering mandating police in schools when the Ontario Human Rights Commission and mountains of evidence have already found that a police presence not only introduces unnecessary surveillance but also significantly impacts the mental health and education of Indigenous, black and racialized kids,' said Hornick. The legislation reaches into post-secondary education as well. Requiring colleges and universities to adopt rigid and restrictive admissions policies - defined by the province - ignores decades of work done to widen access for underrepresented groups. Stripping away access-focused admissions pathways threatens the socio-economic mobility of entire communities. 'They want to surveil and criminalize our kids from a young age and then make it even harder to access post-secondary education later on in their academic careers. Ontario's future depends on an inclusive education system, not one that intentionally keeps people out,' said Hornick. The province's colleges system is already in crisis, receiving the lowest level of provincial funding per student in the country. Bill 33 threatens to further destabilize campuses by adding more ministerial oversight over ancillary fees that fund student-led services like mental health supports, food banks, and student career services. 'This legislation would not only strip students of their ability to democratically decide which of these services matter to them,' said Hornick. 'It is clearly intended to defund these services in our colleges.'
Yahoo
an hour ago
- Yahoo
Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference
NOVATO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil Kakkis, M.D., Ph.D., the company's chief executive officer, will participate in a fireside at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025, at 10:00 a.m. ET. The live and archived webcast of the panel will be accessible from the company's website at About Ultragenyx Pharmaceutical Inc. Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx's strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency. For more information on Ultragenyx, please visit the company's website at: Contacts – Ultragenyx Pharmaceutical, Higa ir@
Yahoo
2 hours ago
- Yahoo
Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference
NOVATO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil Kakkis, M.D., Ph.D., the company's chief executive officer, will participate in a fireside at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025, at 10:00 a.m. ET. The live and archived webcast of the panel will be accessible from the company's website at About Ultragenyx Pharmaceutical Inc. Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx's strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency. For more information on Ultragenyx, please visit the company's website at: Contacts – Ultragenyx Pharmaceutical, Higa ir@
